Clader J W, Berger J G, Burrier R E, Davis H R, Domalski M, Dugar S, Kogan T P, Salisbury B, Vaccaro W
Schering-Plough Research Institute, Kenilworth, New Jersey 07033-0539, USA.
J Med Chem. 1995 May 12;38(10):1600-7. doi: 10.1021/jm00010a004.
Substituted (1,2-diarylethyl)amides have been prepared and evaluated for their ability to inhibit microsomal acyl-CoA:cholesterol acyltransferase activity in vitro and to lower hepatic cholesteryl ester content in vivo in a cholesterol-fed hamster. Simple unsubstituted (diarylethyl)amides were potent inhibitors in vitro but showed poor activity in vivo. Introduction of polar groups at specific locations on the diarylethylamine moiety decreased in vitro activity but increased in vivo activity. Both effects were highly structure dependent, suggesting specific interactions which were mediating activity in each model. Optimization of these opposing effects led to compounds which were potent in both models.
